A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor

scientific article published on March 1, 1992

A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/J.1460-2075.1992.TB05140.X
P953full work available at URLhttps://europepmc.org/articles/PMC556542
https://europepmc.org/articles/PMC556542?pdf=render
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1347744/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1347744/pdf/?tool=EBI
P932PMC publication ID556542
P698PubMed publication ID1347744

P2093author name stringA. Baniahmad
R. Renkawitz
A. C. Köhne
P2860cites workMutations that alter both localization and production of a yeast nuclear proteinQ61631665
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cellsQ27860607
The steroid and thyroid hormone receptor superfamilyQ27861095
Identification of a receptor for the morphogen retinoic acidQ28280559
The c-erb-A protein is a high-affinity receptor for thyroid hormoneQ28282719
The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptorsQ28297907
Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequenceQ29547917
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptorsQ29615768
How eukaryotic transcriptional activators workQ29618289
v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) geneQ34553519
v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.Q35000459
Ecdysterone regulatory elements function as both transcriptional activators and repressorsQ36687580
c-erbA encodes multiple proteins in chicken erythroid cellsQ36846588
Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogeneQ36847673
Transcriptional repression in eukaryotesQ37941786
Multiple cell type-specific proteins differentially regulate target sequence recognition by the alpha retinoic acid receptorQ38338308
Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding siteQ38340913
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptorQ38341530
Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repressionQ38341818
Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimerQ38343050
Transcriptional repression of eukaryotic promotersQ38365817
Nuclear receptors enhance our understanding of transcription regulationQ39324380
Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformationQ40136598
New Procedure for DNA Transfection with Polycation and Dimethyl SulfoxideQ40675293
Active repression of transcription by the engrailed homeodomain proteinQ41080980
Characterization of the hormone-binding domain of the chicken c-erbA/thyroid hormone receptor proteinQ41090648
A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptorsQ41274369
A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenesQ41333116
Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elementsQ41347641
Depletion of L-3,5,3'-Triiodothyronine and L-Thyroxine in Euthyroid Calf Serum for Use in Cell Culture Studies of the Action of Thyroid Hormone*Q41621030
Regulation of progesterone receptor-mediated transcription by phosphorylationQ41710148
Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptorQ42494510
The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elementsQ43679715
An amino-terminal fragment of GAL4 binds DNA as a dimerQ44240938
Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonistQ44537287
Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activityQ45217737
Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression.Q45953874
Retinoic acid and thyroid hormone induce gene expression through a common responsive element.Q46001994
A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1.Q46963035
Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous systemQ48205412
Proliferation and differentiation of embryonic chick sympathetic neurons: effects of ciliary neurotrophic factor.Q52247249
Developmental regulation of beta-globin gene switching.Q52249886
Drosophila Krüppel protein is a transcriptional repressor.Q52449047
A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives.Q54713263
Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene productQ59098062
P433issue3
P407language of work or nameEnglishQ1860
P921main subjecttretinoinQ29417
P304page(s)1015-23
P577publication date1992-03-01
P1433published inThe EMBO JournalQ1278554
P1476titleA transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor
P478volume11

Reverse relations

cites work (P2860)
Q40017010A Domain of the even-skipped Protein Represses Transcription by Preventing TFIID Binding to a Promoter: Repression by Cooperative Blocking
Q39663814A Novel Cytoplasmic Adaptor for Retinoic Acid Receptor (RAR) and Thyroid Receptor Functions as a Derepressor of RAR in the Absence of Retinoic Acid*
Q36573257A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release
Q36686878A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Q33844628A highly selective, label-free, homogenous luminescent switch-on probe for the detection of nanomolar transcription factor NF-kappaB.
Q39447809A novel role for helix 12 of retinoid X receptor in regulating repression
Q38352823A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains.
Q35686843A regulatory system for use in gene transfer
Q39471038A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor
Q36556770A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha
Q24683893Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu
Q36560941Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states
Q24554508Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily
Q36570703Both thyroid hormone and 9-cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis
Q40396342COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells
Q37376082CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
Q34166628CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab-8 insulator
Q36078330Characterization of downstream elements in a Raf-1 pathway
Q40792409Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor
Q24648169Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex
Q36574046Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression
Q40015630Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates
Q35563843DAX1 and its network partners: exploring complexity in development
Q33886757Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation
Q40023991Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression
Q35875001Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor
Q38309584Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha
Q33888108Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase.
Q24514479Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation
Q24313680ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation
Q40016745Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer
Q24533137Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter
Q40873357Functional domains of the Drosophila Engrailed protein
Q40023148Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression
Q36664756Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor
Q36211947Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants
Q40480355Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.
Q37175215Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties
Q36666829Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha
Q36556508Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone
Q24533537Involvement of negative cofactor NC2 in active repression by zinc finger-homeodomain transcription factor AREB6
Q37290828Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses
Q42663412Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Q24313231Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex
Q37337779Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding
Q78252318Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription
Q36655046Mapping and mutagenesis of the amino-terminal transcriptional repression domain of the Drosophila Krüppel protein
Q38358466Molecular mechanisms of COUP-TF-mediated transcriptional repression: evidence for transrepression and active repression
Q36566667Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region
Q37251354Multiple mutations contribute to repression by the v-Erb A oncoprotein
Q39723148Multiple receptor interaction domains of GRIP1 function in synergy
Q41036772Multiple steps in the regulation of transcription-factor level and activity
Q36570551Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.
Q40021079Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF.
Q40800435Negative regulation of transcription in eukaryotes
Q28367742New retinoid X receptor subtypes in zebra fish (Danio rerio) differentially modulate transcription and do not bind 9-cis retinoic acid
Q34448240Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation
Q35202493Proteasomal regulation of nuclear receptor corepressor-mediated repression
Q24548135Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1
Q36569110Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor
Q36760762Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region
Q37241518Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha
Q36813375SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers
Q22009109SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor
Q33716064Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor beta
Q24684065Steroid receptor induction of gene transcription: a two-step model
Q40020247The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal
Q40017152The Transcriptional Repressor Even-skipped Interacts Directly with TATA-Binding Protein
Q38321491The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
Q42508346The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation
Q38354882The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K.
Q36822461The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms
Q37229683The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor
Q40015924The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation
Q36675733The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3.
Q36554302The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat
Q28263578The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor
Q24646988The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing
Q34569982Thyroid hormone and leptin in the testis.
Q33295447Thyroid hormone receptor orthologues from invertebrate species with emphasis on Schistosoma mansoni
Q41119685Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors
Q58748789Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4
Q34294723Transcription factors as drug targets: opportunities for therapeutic selectivity.
Q34748840Transcriptional activation by the orphan nuclear receptor ARP-1.
Q37241513Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex
Q34610377Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR.
Q33779119Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.
Q34798810Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain
Q39465831Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor
Q33780043Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors
Q24543959Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors
Q40231308Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.
Q24310721Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression
Q39454178tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors

Search more.